Pfizer Incorporated
Company Income Statement
| Dec 2007 | Dec 2006 | Dec 2005 | Dec 2004 | |
| Sales | 48.42B | 48.37B | 51.30B | 52.52B |
| Cost of Sales | 9.17B | 5.61B | 6.36B | 5.81B |
| Gross Operating Profit | 39.25B | 42.76B | 44.94B | 46.70B |
| Selling, General, and Administrative Expenses | 8.09B | 7.60B | 7.44B | 7.68B |
| Research & Development | 15.63B | 15.59B | 17.00B | 16.90B |
| Operating Income before D & A (EBITDA) | 15.54B | 19.58B | 20.50B | 22.12B |
| Depreciation & Amortization | 5.20B | 5.29B | 5.58B | 5.09B |
| Interest Income | 1.50B | 925.00M | 740.00M | 346.00M |
| Other Income - Net | 660.00M | 787.00M | 542.00M | -50.00M |
| Special Income / Charges | 0.00 | -320.00M | -1.16B | -702.00M |
| Total Income Before Interest Expenses (EBIT) | 9.68B | 13.52B | 12.00B | 14.35B |
| Interest Expense | 397.00M | 488.00M | 471.00M | 347.00M |
| Pre-Tax Income | 9.28B | 13.03B | 11.53B | 14.01B |
| Income Taxes | 1.02B | 1.99B | 3.42B | 2.66B |
| Minority Interest | 42.00M | 12.00M | 16.00M | 10.00M |
| Net Income From Continuing Operations | 8.21B | 11.02B | 8.09B | 11.33B |
| Net Income From Discontinued Operations | -69.00M | 8.31B | 16.00M | 29.00M |
| Net Income From Total Operations | 8.14B | 19.34B | 8.11B | 11.36B |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | -25.00M | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 8.14B | 19.34B | 8.08B | 11.36B |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
11.03B | 13.50B | 12.30B | 14.30B |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 8.21B | 11.02B | 8.09B | 11.33B |
| Basic EPS from Continuing Ops. | 1.19 | 1.52 | 1.10 | 1.51 |
| Basic EPS from Discontinued Ops. | -0.01 | 1.15 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 1.18 | 2.67 | 1.10 | 1.51 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 1.18 | 2.67 | 1.10 | 1.51 |
| Basic Normalized Net Income/Share | 1.60 | 1.86 | 1.67 | 1.91 |
| EPS fr Continuing Ops. | 1.18 | 1.52 | 1.09 | 1.49 |
| EPS fr Discontinued Ops | -0.01 | 1.14 | 0.00 | 0.00 |
| EPS fr Total Ops. | 1.17 | 2.66 | 1.09 | 1.49 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 1.17 | 2.66 | 1.09 | 1.49 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
1.58 | 1.86 | 1.66 | 1.88 |
| Dividends Paid per Share | 1.16 | 0.96 | 0.76 | 0.68 |
Quotes
News & Commentary
Financials
Company Information
Ratings
Find more premium investing ideas